Invicta Diagnostic
add_icon

Invicta Diagnostic

68.30
-1.60
(-2.29%)
Market Cap
85.87 Cr
PE Ratio
18.02
Volume
6,400.00
Day High - Low
69.90 - 68.30
52W High-Low
105.00 - 58.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
85.87 Cr
EPS
4.90
PE Ratio
18.02
PB Ratio
1.76
Book Value
39.71
EBITDA
10.50
Dividend Yield
0.00 %
Return on Equity
9.76
Debt to Equity
0.11
Forecast For
Actual

Company News

View All News
Caret
neutral
Invicta Diagnostic's subsidiary Porteus Medical LLP incorporated Porteus Pathogenius LLP as a step-down subsidiary with an initial capital contribution of ₹51,000 for a 51% stake.
neutral
Invicta Diagnostic Limited announced that its subsidiary, Porteus Medical LLP, has incorporated Porteus Pathogenius LLP as a step-down subsidiary with a 51% stake.
positive
Invicta Diagnostic Limited expanded its tele-radiology services to the United States on May 22, 2026, marking its entry into the international market.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,927.00
#1 32,303.80
58.79
#1 2,864.20
12.11
#1 510
27.24
57.12
1,505.50
15,491.10
81.36
814.20
16.36
182
37.56
56.00
591.25
12,258.25
59.51
1,671.40
24.15
191
25.61
57.67
578.00
9,199.76
52.12
846.00
20.48
163
33.94
46.96
707.00
7,094.09
81.66
1,023.40
32.93
77
35.02
52.30
550.95
1,787.21
18.46
772.77
4.05
106
-19.51
48.62
340.40
1,772.83
50.50
310.41
21.30
34
40.22
72.67
1,486.20
1,275.56
22.58
141.92
27.17
61
-28.57
71.50
527.15
1,030.21
#1 13.27
498.18
#1 237.06
69
#1 45.92
-
290.40
923.78
-36.63
1,319.27
12.68
-3
-92.48
43.63

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
9.27 %
Net Income Growth
-
Cash Flow Change
-55.34 %
ROE
-73.08 %
ROCE
-63.01 %
EBITDA Margin (Avg.)
2.83 %

Yearly Financial Results

Annual Financials
2024
2025
2026
TTM
Revenue
8
30
33
0
Expenses
5
21
23
0
EBITDA
4
9
11
0
Operating Profit %
43 %
31 %
30 %
0 %
Depreciation
1
3
3
0
Interest
0
0
0
0
Profit Before Tax
3
7
7
0
Tax
0
2
2
0
Net Profit
3
5
5
0
EPS in ₹
3.19
5.86
4.90
0.00

Balance Sheet

Balance Sheet
2024
2025
2026
Total Assets
16
21
60
Fixed Assets
12
10
19
Current Assets
4
6
34
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
4
12
41
Total Equity & Liabilities
16
21
60
Current Liabilities
2
3
7
Non Current Liabilities
3
5
3
Total Equity
11
14
50
Reserve & Surplus
12
5
37
Share Capital
0
8
13

Cash Flow

Cash Flow
2024
2025
2026
Net Cash Flow
1
1
20
Investing Activities
-10
-5
-14
Operating Activities
4
7
3
Financing Activities
7
-1
31

Share Holding

% Holding
Aug 2024
Nov 2025
Dec 2025
Mar 2026
Promoter
100.00 %
90.52 %
66.70 %
66.70 %
FIIs
0.00 %
0.00 %
0.94 %
4.20 %
DIIs
0.00 %
0.00 %
10.22 %
4.30 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
18.49 %
18.71 %
Others
0.00 %
9.48 %
3.66 %
6.10 %
No of Share Holders
14
34
34
411

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Apr 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
17 Apr 2026 71.25 73.20
18 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 May 2026 86.10 89.50
25 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Aug 2026 70.00 70.00

Technical Indicators

RSI(14)
Neutral
48.65
ATR(14)
Less Volatile
2.82
STOCH(9,6)
Neutral
33.80
STOCH RSI(14)
Neutral
25.80
MACD(12,26)
Bearish
-0.48
ADX(14)
Weak Trend
16.81
UO(9)
Bearish
38.32
ROC(12)
Downtrend And Accelerating
-9.22
WillR(14)
Neutral
-71.67